Vitamin B12 Deficiency Treatment

Some people with confirmed or suspected vitamin B12 deficiency can be assessed online. The clinician will review symptoms, blood-test results, diet, gastrointestinal surgery, malabsorption, medicines, pregnancy or breastfeeding, nitrous oxide exposure and any neurological symptoms.

New or progressive neurological symptoms, severe anaemia, marked weakness, gait disturbance or rapidly worsening symptoms may require urgent or face-to-face assessment.

NICE recommends taking blood samples for diagnostic testing before starting vitamin B12 replacement where possible. However, treatment should not be delayed in people with suspected megaloblastic anaemia and neurological symptoms, particularly where subacute combined degeneration is a concern.

NICE recommends either total vitamin B12 or active vitamin B12 as the initial test in most people. Active B12 is preferred during pregnancy. If nitrous oxide is the suspected cause, methylmalonic acid or homocysteine testing is used instead.

Yes. NICE specifically advises not ruling out vitamin B12 deficiency simply because anaemia or macrocytosis is absent. Neurological, cognitive or other symptoms can occur without classic blood-count changes.

Vitamin B12 is needed for normal red-blood-cell formation, DNA synthesis and healthy neurological function. Deficiency can affect both the blood and nervous system.

Symptoms can include fatigue, weakness, pallor, breathlessness, sore tongue, pins and needles, numbness, balance problems, memory or concentration changes and other neurological or psychological symptoms.

Yes. Deficiency can cause numbness, tingling, altered sensation, weakness, gait or balance problems and cognitive symptoms. Neurological damage can become irreversible if severe deficiency is left untreated.

Yes. NICE notes that vitamin B12 deficiency can be associated with mental-health and cognitive symptoms, including depression, anxiety, psychosis and cognitive impairment.

Hydroxocobalamin is an injectable form of vitamin B12 used to treat and prevent vitamin B12 deficiency, including pernicious anaemia and other macrocytic anaemias caused by deficiency.

Hydroxocobalamin for vitamin B12 deficiency is administered by intramuscular injection. The loading and maintenance schedule depends on the cause of deficiency and whether neurological involvement is present.

Current UK product information lists Hydroxocobalamin 1 mg intramuscularly on alternate days for vitamin B12 deficiency with neurological involvement, continuing while improvement is occurring.

Current UK product information commonly uses Hydroxocobalamin 1 mg intramuscularly every 2 months for maintenance after deficiency with neurological involvement.

Licensed product information describes intramuscular loading on alternate days for 1 to 2 weeks, followed by weekly treatment until the blood count is normal. In current UK clinical practice, the exact regimen should be selected according to the product information and clinical circumstances.

For pernicious anaemia and other irreversible causes without neurological involvement, licensed UK product information commonly uses Hydroxocobalamin 1 mg intramuscularly every 2 to 3 months for maintenance.

NICE advises that symptoms may begin improving within about 2 weeks, although improvement can take up to 3 months and neurological recovery can take considerably longer.

Possible effects include injection-site reactions, headache, dizziness, nausea, rash and acne-like eruptions. Serious allergic reactions are rare but require urgent medical attention.

Pernicious anaemia is a form of vitamin B12 deficiency caused by impaired absorption related to autoimmune gastritis and loss of intrinsic-factor function. NICE now commonly uses the term autoimmune gastritis when describing this cause.

Yes. NICE recommends lifelong intramuscular vitamin B12 replacement when autoimmune gastritis is the confirmed or suspected cause of deficiency.

NICE recommends lifelong intramuscular vitamin B12 replacement after total gastrectomy because normal vitamin B12 absorption is permanently impaired.

NICE recommends lifelong intramuscular replacement after complete terminal ileal resection because the main site of vitamin B12 absorption has been removed.

Yes. Coeliac disease and other malabsorption conditions can contribute to vitamin B12 deficiency. NICE recommends considering coeliac serology when the cause remains unexplained after initial investigation.

Yes. Several bariatric procedures, including gastric bypass and sleeve gastrectomy, can reduce vitamin B12 absorption and may require long-term oral or intramuscular replacement depending on the operation and clinical response.

Yes. Vitamin B12 is naturally found mainly in animal-derived foods, so a prolonged low intake can cause deficiency, particularly in people following a strict vegan diet without adequate supplementation or fortified foods.

No. NICE allows oral vitamin B12 replacement for many dietary deficiencies. Intramuscular treatment may be preferred when symptoms are severe, adherence is a concern or rapid replacement is clinically important.

Yes. Long-term Metformin use is a recognised risk factor for reduced vitamin B12 levels. People with symptoms or additional risk factors may need testing and replacement while Metformin treatment is continued when clinically appropriate.

Long-term acid-suppressing medicines, including proton pump inhibitors and H2-receptor antagonists, can reduce vitamin B12 absorption in some people and are recognised by NICE as risk factors.

Yes. Recreational nitrous oxide can inactivate vitamin B12 and cause serious neurological deficiency even when the measured serum B12 concentration is not clearly low. NICE recommends methylmalonic acid or homocysteine testing when nitrous oxide is the suspected cause.

Yes. Pregnancy can alter interpretation of vitamin B12 tests and untreated deficiency may affect both parent and baby. NICE recommends active B12 as the initial test during pregnancy and earlier follow-up after treatment starts.

An anti-intrinsic-factor antibody test can support a diagnosis of autoimmune gastritis when this is suspected as the cause of vitamin B12 deficiency. A negative result does not completely exclude autoimmune gastritis.

Methylmalonic acid, or MMA, rises when cellular vitamin B12 is insufficient and can help clarify an indeterminate B12 result. It is also used in the assessment of suspected nitrous-oxide-related deficiency.

Homocysteine can rise in vitamin B12 deficiency, although folate deficiency and other factors can also increase it. NICE recommends interpreting it against the laboratory reference range and clinical context.

Folate deficiency can coexist with vitamin B12 deficiency and can produce similar blood-count changes. If megaloblastic anaemia does not respond as expected, folate metabolism and other diagnoses should be reviewed.

Yes. NICE recommends an initial follow-up around 3 months after starting replacement, or earlier depending on symptom severity. Pregnancy or breastfeeding generally warrants follow-up at about 1 month.

NICE advises not repeating the initial diagnostic vitamin B12 test in people receiving intramuscular replacement. Follow-up should focus on symptoms, response and the underlying cause.

NICE advises considering a higher injection frequency where appropriate, in line with product information, while also reviewing adherence, alternative diagnoses and whether symptoms have another cause.

Yes, when the cause is reversible and has been fully addressed, treatment may sometimes be stopped after clinical review. Irreversible causes such as autoimmune gastritis, total gastrectomy or complete terminal ileal resection require lifelong replacement.

New or rapidly progressive weakness, marked gait disturbance, significant loss of coordination, severe sensory change, confusion, severe anaemia symptoms or concern about spinal-cord involvement requires prompt medical assessment.

It is a serious neurological complication of vitamin B12 deficiency that can cause altered sensation, weakness, impaired balance and gait disturbance. NICE advises not delaying B12 replacement when it is suspected.

Rapid production of new blood cells during initial treatment of severe megaloblastic anaemia can rarely contribute to hypokalaemia. Some product information advises potassium monitoring during intensive initial treatment in higher-risk cases.

Vitamin B12 replacement should not be stopped simply because of pregnancy or breastfeeding. NICE advises continuing replacement when it was already started and reviewing treatment appropriately.

Maintenance injections may be appropriate when the cause is irreversible or ongoing. The interval depends on the clinical indication, neurological involvement and product-specific dosing schedule.

Provide recent blood results if available, details of neurological symptoms, gastrointestinal surgery or disease, diet, current medicines, pregnancy or breastfeeding status and any nitrous oxide exposure.

If intramuscular Hydroxocobalamin is clinically appropriate, the treatment plan should clearly state the loading regimen, maintenance interval, monitoring requirements and when further medical assessment is needed.